The team

Built by scientists and serial entrepreneurs.

reThink64 brings together founders and researchers who have spent their careers in large-molecule biotech, delivery and commercialization. People who have overcome the challenges of large-molecule development in the past and are passionate about creating better solutions for developers and, ultimately, for patients.

Get in touch See the platform

Leadership

The team.

Jay Sarkar, PhD

Chief Executive Officer

Pioneer of mRNA partial reprogramming. Two-time founder building at the frontier of large-molecule medicine, formerly at Stanford Medicine and Turn Bio.

Akira Yamamoto, MS

Chief Technology Officer

20+ patents and multiple commercial products. Two-time founder with deep formulation and delivery expertise, formerly at Pentax Medical and Stanford Research Institute.

Tara Mirzadegan, PhD

Chief Business Officer

30+ year pharma executive. Computational chemistry background, 80+ patents and publications, formerly at Ferring, Roche and Johnson & Johnson.

Joseph Pazzi, PhD

Director of Formulation

Bioengineering, UC Merced. Expertise in membrane biophysics, with 20+ publications and patents.

Harrison Miller, MBA

Director of Business Development

AI/ML drug design and 5+ years in large-molecule biotech, partnering and business development, formerly at Alnylam Pharmaceuticals. HBS MBA.

Advisors

Dr. Avnesh Thakor

Precision Delivery, Stanford

Professor of interventional radiology and precision delivery at Stanford.

Dr. Kiyotaka Shiba

Protein Engineering, JFCR

Department head at the Japanese Foundation for Cancer Research, working on biological delivery mechanisms.

Dr. Albert Wu

Oculoplastic Surgery, Stanford and University of Ottawa

Director-level clinician on ophthalmic clinical applications.

Dr. Brent Hermsmeier

Hardware & Healthcare

Two-time founder and executive with 30+ years in hardware and healthcare.

Earlier talks

Talks by Jay Sarkar listed under Stanford University.

Oct 23 to 24, 2024RNA Therapeutics USA. Talk: Novel Constructs for Network-Mediated Large Molecule Drug Delivery. Listed as Stanford University.
Jun 14 to 15, 2023RNA Therapeutics USA. Talk on RNA cocktail approaches and combinational therapy distribution. Listed as Stanford University.
Jan 16 to 17, 2023PepTalk 2023. Chairperson's remarks and talk on intraorganelle localization of peptide, protein and oligo conjugated actives. Listed as Visiting Scholar, Stanford University.

Built and backed at

Team experience spans

Let's connect

Want to work with this team?

Whether you are a partner with a formulation problem or an investor who shares the thesis, we would like to hear from you.

Get in touch